Welcome!

News Feed Item

Health Care Stocks Review -- Research on Quest Diagnostics, Organovo Holdings, Agilent Technologies, and Thermo Fisher Scientific

Editor Note: For more information about this release, please scroll to bottom.

LONDON, March 24, 2014 /PRNewswire/ --

 


On Friday, March 21, 2014, the NASDAQ Composite finished at 4,276.79, down 0.98%. The Dow Jones Industrial Average closed the session at 16,302.77, down 0.17% and the S&P 500 ended the day at 1,866.52, lower by 0.29%. Four out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day 1.54% lower at 675.70 and the same has declined 1.28% in the last one month. Investor-Edge has initiated coverage on the following equities: Quest Diagnostics Inc. (NYSE: DGX), Organovo Holdings Inc. (NYSE MKT: ONVO), Agilent Technologies Inc. (NYSE: A) and Thermo Fisher Scientific Inc. (NYSE: TMO). Free technical research on DGX, ONVO, A and TMO can be downloaded upon signing up at:

http://www.investor-edge.com/445-register


On Friday, Quest Diagnostics Inc.'s stock edged 0.16% higher, finishing the session at $55.77. The stock recorded a trading volume of 2.82 million shares as compared to a three months average volume of 2.38 million shares. The stock fluctuated between $55.50 and $56.09 during the session. Shares of the company traded at a PE ratio of 14.89. Quest Diagnostics Inc.'s stock has advanced 1.12% in the previous three trading sessions, 5.13% in the last one month, and 4.17% on YTD basis. The stock is trading above its 50-day moving average. Quest Diagnostics Inc.'s 200-day moving average of $58.03 is above the 50-day moving average of $53.26. Moreover, the stock is trading at an Relative Strength Index (RSI) of 68.88. Sign up today to read free research on DGX at:

http://www.investor-edge.com/445-DGX-24Mar2014.pdf


Organovo Holdings Inc.'s stock reported a trading volume of 3.10 million shares, as compared with a three months average volume of 3.32 million shares. The stock ended the day at $8.45, down 3.21% after fluctuating between $8.08 and $8.83. Organovo Holdings Inc.'s shares have declined 6.63% in the previous three trading sessions and 23.67% on YTD basis. The stock is trading above its 200-day moving average. Organovo Holdings Inc.'s 50-day moving average of $9.79 is above the 200-day moving average of $7.48. Furthermore, the stock is trading at an RSI of 35.28. Sign up today to read free research on ONVO at:

http://www.investor-edge.com/445-ONVO-24Mar2014.pdf


On Friday, shares in Agilent Technologies Inc. stock declined 1.08% to close at $56.09. A total of 2.76 million shares were traded, which is above the three months average volume of 2.75 million. The stock oscillated between $55.96 and $57.78 during the trading session. Shares of the company traded at a PE ratio of 22.25.  Agilent Technologies Inc.'s shares have declined 1.23% in the previous three trading sessions and 1.92% on YTD basis. The stock is trading above its 200-day moving average. Agilent Technologies Inc.'s 50-day moving average of $57.90 is trading above the 200-day moving average of $51.70. Furthermore, the stock is trading at an RSI of 44.21. Sign up today to read free research on A at:

http://www.investor-edge.com/445-A-24Mar2014.pdf


Shares in Thermo Fisher Scientific Inc. registered a trading volume of 4.44 million shares, as compared with a three months average volume of 2.51 million shares. The stock ended the day at $122.90, down 0.55% after vacillating between $122.84 and $125.87. Shares of the company traded at a PE ratio of 35.15. Thermo Fisher Scientific Inc.'s shares have fallen by 0.23% in the last one month, while the same has advanced 10.37% on YTD basis. Further, the company's stock is trading above its 50-day and 200-day moving averages. Thermo Fisher Scientific Inc.'s 50-day moving average of $119.64 is above the 200-day moving average of $100.64. Additionally, shares of the company are trading at an RSI of 50.95. Sign up today to read free research on TMO at:

http://www.investor-edge.com/445-TMO-24Mar2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Investor-Edge.com

SOURCE Investor-Edge

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In past @ThingsExpo presentations, Joseph di Paolantonio has explored how various Internet of Things (IoT) and data management and analytics (DMA) solution spaces will come together as sensor analytics ecosystems. This year, in his session at @ThingsExpo, Joseph di Paolantonio from DataArchon, added the numerous Transportation areas, from autonomous vehicles to “Uber for containers.” While IoT data in any one area of Transportation will have a huge impact in that area, combining sensor analytic...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
Michael Maximilien, better known as max or Dr. Max, is a computer scientist with IBM. At IBM Research Triangle Park, he was a principal engineer for the worldwide industry point-of-sale standard: JavaPOS. At IBM Research, some highlights include pioneering research on semantic Web services, mashups, and cloud computing, and platform-as-a-service. He joined the IBM Cloud Labs in 2014 and works closely with Pivotal Inc., to help make the Cloud Found the best PaaS.
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
In a world where the internet rules all, where 94% of business buyers conduct online research, and where e-commerce sales are poised to fall between $427 billion and $443 billion by the end of this year, we think it's safe to say that your website is a vital part of your business strategy. Whether you're a B2B company, a local business, or an e-commerce site, digital presence is key to maintain in your drive towards success. Digital Performance will take priority in 2018 for the following reason...
At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
I think DevOps is now a rambunctious teenager - it's starting to get a mind of its own, wanting to get its own things but it still needs some adult supervision," explained Thomas Hooker, VP of marketing at CollabNet, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...